Company / Shares Outstanding
Amgen Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
536.9M
FY2025
5-year range
534.0M / 578.3M
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#20 of 212
Health Care
What the data says
Among 212 Health Care companies, Amgen is in the bottom 9% for shares outstanding.
Based on SEC 10-K filings.
536900000.00 in FY2025 with a 5-year CAGR of -1.9%. Top quartile in the Health Care sector.
Remained stable around 536900000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 212This company 536.9M Sector average 306.3M
▼
+75.3% above sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.3% year-over-year.
- Ranks #20 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2016.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 536.9M | +0.3% |
| FY2024 | 535.4M | +0.3% |
| FY2023 | 534.0M | -4.4% |
| FY2022 | 558.3M | -3.5% |
| FY2021 | 578.3M | -2.2% |
| FY2020 | 591.4M | -6.1% |
| FY2019 | 629.6M | -12.8% |
| FY2018 | 722.2M | -2.2% |
| FY2017 | 738.2M | -2.1% |
| FY2016 | 754.0M | -0.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026